Cells of the retina, which detect light from the back of the eye, are a part of the central nervous system (CNS). Unlike other parts of the body, the CNS cannot heal itself once it is damaged by injury or disease. This makes degenerative eye diseases like retinitis pigmentosa (RP)—a genetic disorder that causes progressive damage to retinal cells—incurable. RP can cause blindness, and symptoms typically begin to appear during adolescence.
The team remains hard at work on multiple preclinical projects, all due to be completed this year. The results of these critical translational studies will […]
Henry Klassen, M.D., Ph.D., is only about a year from launching a clinical trial for a stem cell treatment to rescue vision in people with […]
The team remains hard at work in our effort to bring retinal progenitor cells to clinical trials. The work being conducted now is centered on accumulating […]
The past two months have been very active. We have begun final preparations to launch the formal research studies for our upcoming FDA application to […]
Many people impacted by retinal degeneration are eager to hear updates on our upcoming clinical trial to test retinal progenitor cells as a treatment for retinitis pigmentosa. […]
This is our first update, and I want to acknowledge and thank those who have provided encouragement and positive feedback. The RP disease team successfully […]
Henry Klassen, MD, PhD, associate professor of ophthalmology at UC Irvine’s Sue & Bill Gross Stem Cell Research Center, and collaborators at UC Santa Barbara and […]